Brown Brothers Harriman & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.9M | Sell |
327,905
-16,584
| -5% | -$434K | 0.03% | 173 |
|
|
2026
Q1 | $9.67M | Buy |
344,489
+134,886
| +64% | +$3.59M | 0.05% | 146 |
|
|
2025
Q4 | $5.22M | Buy |
209,603
+20,355
| +11% | +$513K | 0.03% | 173 |
|
|
2025
Q3 | $4.82M | Buy |
189,248
+3,875
| +2% | +$95.6K | 0.03% | 165 |
|
|
2025
Q2 | $4.49M | Buy |
185,373
+23,812
| +15% | +$555K | 0.03% | 163 |
|
|
2025
Q1 | $4.09M | Sell |
161,561
-15,512
| -9% | -$406K | 0.03% | 167 |
|
|
2024
Q4 | $4.7M | Sell |
177,073
-33,854
| -16% | -$918K | 0.03% | 155 |
|
|
2024
Q3 | $6.1M | Buy |
210,927
+6,232
| +3% | +$182K | 0.04% | 135 |
|
|
2024
Q2 | $5.73M | Sell |
204,695
-5,911
| -3% | -$163K | 0.04% | 134 |
|
|
2024
Q1 | $5.84M | Buy |
210,606
+5,736
| +3% | +$159K | 0.04% | 128 |
|
|
2023
Q4 | $5.9M | Sell |
204,870
-28,334
| -12% | -$857K | 0.05% | 129 |
|
|
2023
Q3 | $7.74M | Buy |
233,204
+4,666
| +2% | +$165K | 0.07% | 110 |
|
|
2023
Q2 | $8.38M | Sell |
228,538
-1,036
| -0.5% | -$40.3K | 0.07% | 98 |
|
|
2023
Q1 | $9.37M | Buy |
229,574
+463
| +0.2% | +$20K | 0.08% | 83 |
|
|
2022
Q4 | $11.7M | Sell |
229,111
-30,250
| -12% | -$1.45M | 0.1% | 71 |
|
|
2022
Q3 | $11.3M | Sell |
259,361
-11,849
| -4% | -$576K | 0.11% | 70 |
|
|
2022
Q2 | $14.2M | Buy |
271,210
+7,406
| +3% | +$377K | 0.12% | 68 |
|
|
2022
Q1 | $13.7M | Sell |
263,804
-5,170
| -2% | -$268K | 0.1% | 75 |
|
|
2021
Q4 | $15.9M | Buy |
268,974
+13,043
| +5% | +$646K | 0.09% | 74 |
|
|
2021
Q3 | $11M | Sell |
255,931
-17,743
| -6% | -$786K | 0.07% | 84 |
|
|
2021
Q2 | $10.7M | Sell |
273,674
-4,589
| -2% | -$178K | 0.06% | 85 |
|
|
2021
Q1 | $10.1M | Sell |
278,263
-59,825
| -18% | -$2.12M | 0.06% | 89 |
|
|
2020
Q4 | $12.4M | Sell |
338,088
-8,140
| -2% | -$299K | 0.08% | 76 |
|
|
2020
Q3 | $12.1M | Sell |
346,228
-1,915
| -0.6% | -$67.1K | 0.09% | 73 |
|
|
2020
Q2 | $10.8M | Buy |
348,143
+8,930
| +3% | +$303K | 0.08% | 74 |
|
|
2020
Q1 | $10.5M | Sell |
339,213
-30,869
| -8% | -$1.05M | 0.09% | 74 |
|
|
2019
Q4 | $13.8M | Buy |
370,082
+7,582
| +2% | +$270K | 0.09% | 78 |
|
|
2019
Q3 | $12.4M | Buy |
362,500
+49,359
| +16% | +$1.79M | 0.08% | 80 |
|
|
2019
Q2 | $12.9M | Buy |
313,141
+14,405
| +5% | +$572K | 0.09% | 75 |
|
|
2019
Q1 | $12M | Sell |
298,736
-4,594
| -2% | -$184K | 0.08% | 78 |
|
|
2018
Q4 | $12.6M | Sell |
303,330
-1,250
| -0.4% | -$51.9K | 0.1% | 70 |
|
|
2018
Q3 | $12.7M | Buy |
304,580
+251
| +0.1% | +$9.66K | 0.08% | 71 |
|
|
2018
Q2 | $10.5M | Sell |
304,329
-1,897
| -0.6% | -$64.8K | 0.06% | 75 |
|
|
2018
Q1 | $10.3M | Sell |
306,226
-17,483
| -5% | -$601K | 0.06% | 73 |
|
|
2017
Q4 | $11.1M | Sell |
323,709
-10,312
| -3% | -$352K | 0.06% | 73 |
|
|
2017
Q3 | $11.3M | Sell |
334,021
-11,363
| -3% | -$365K | 0.06% | 66 |
|
|
2017
Q2 | $11M | Sell |
345,384
-16,065
| -4% | -$507K | 0.06% | 64 |
|
|
2017
Q1 | $11.7M | Sell |
361,449
-14,999
| -4% | -$473K | 0.06% | 65 |
|
|
2016
Q4 | $11.6M | Buy |
376,448
+4,908
| +1% | +$150K | 0.06% | 69 |
|
|
2016
Q3 | $11.9M | Sell |
371,540
-2,478
| -0.7% | -$82.9K | 0.06% | 64 |
|
|
2016
Q2 | $12.5M | Sell |
374,018
-18,569
| -5% | -$593K | 0.06% | 64 |
|
|
2016
Q1 | $11M | Sell |
392,587
-206
| -0.1% | -$5.88K | 0.06% | 68 |
|
|
2015
Q4 | $12M | Sell |
392,793
-17,136
| -4% | -$539K | 0.06% | 66 |
|
|
2015
Q3 | $12.2M | Sell |
409,929
-18,029
| -4% | -$578K | 0.06% | 64 |
|
|
2015
Q2 | $13.6M | Sell |
427,958
-12,807
| -3% | -$417K | 0.06% | 60 |
|
|
2015
Q1 | $14.5M | Buy |
440,765
+7,918
| +2% | +$252K | 0.07% | 62 |
|
|
2014
Q4 | $12.8M | Sell |
432,847
-6,852
| -2% | -$196K | 0.05% | 68 |
|
|
2014
Q3 | $12.3M | Sell |
439,699
-21,546
| -5% | -$605K | 0.05% | 69 |
|
|
2014
Q2 | $13M | Sell |
461,245
-13,136
| -3% | -$374K | 0.05% | 68 |
|
|
2014
Q1 | $14.5M | Sell |
474,381
-510,363
| -52% | -$15.2M | 0.06% | 62 |
|
|
2013
Q4 | $28.6M | Buy |
984,744
+498,289
| +102% | +$14.5M | 0.06% | 62 |
|
|
2013
Q3 | $13.3M | Sell |
486,455
-62,282
| -11% | -$1.69M | 0.06% | 64 |
|
|
2013
Q2 | $14.6M | Buy |
+548,737
| New | +$15.2M | 0.07% | 65 |
|
Other funds holding PFE
Brown Brothers Harriman & Co's PFE Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its Pfizer (PFE) stake by 4.8% in Q2 2026, selling an estimated $434K and leaving 327,905 shares worth $7.9M. The position accounts for 0.03% of the portfolio, ranked #173.
Brown Brothers Harriman & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $28.6M in Q4 2013. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Brown Brothers Harriman & Co held 327,905 shares of Pfizer worth $7.9M as of Q2 2026.
- Brown Brothers Harriman & Co sold 16,584 Pfizer shares in Q2 2026, an estimated $434K.
- Pfizer made up 0.03% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #173 holding.
- Brown Brothers Harriman & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Brown Brothers Harriman & Co's Pfizer position peaked at $28.6M in Q4 2013.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.